help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-0368
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/9/3482    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vidarsdottir, S.
Right arrow Articles by Romijn, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vidarsdottir, S.
Right arrow Articles by Romijn, J. A.
Related Collections
Right arrow Male Endocrinology
Right arrow Neuroendocrinology and Pituitary
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 9 3482-3485
Copyright © 2006 by The Endocrine Society


BRIEF REPORT

Clinical and Biochemical Characteristics of a Male Patient with a Novel Homozygous STAT5b Mutation

Solrun Vidarsdottir1, Marie J. E. Walenkamp1, Alberto M. Pereira, Marcel Karperien, Jaap van Doorn, Hermine A. van Duyvenvoorde, Stefan White, Martijn H. Breuning, Ferdinand Roelfsema, M. Femke Kruithof, Jaap van Dissel, Riny Janssen, Jan M. Wit and Johannes A. Romijn

Departments of Endocrinology and Metabolic Diseases (S.V., A.M.P., M.K., H.A.v.D., F.R., J.A.R.), Pediatrics (M.J.E.W., M.K., H.A.v.D., M.F.K., J.M.W.), and Infectious Diseases (J.v.Di., R.J.) and Center for Human and Clinical Genetics (S.W., M.H.B.), Leiden University Medical Center, Leiden, The Netherlands; and Department of Metabolic and Endocrine Disorders (J.v.Do.), University Medical Center Utrecht, Utrecht, The Netherlands

Address all correspondence and requests for reprints to: M. J. E. Walenkamp, Department of Pediatrics J6-S, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands. E-mail: m.j.e.walenkamp{at}lumc.nl.

Context: GH insensitivity can be caused by defects in the GH receptor (GHR) or in the postreceptor signaling pathway. Recently, two female patients with severe growth retardation and pulmonary and immunological problems were described with a defect in STAT5b, a critical intermediary of downstream GHR signaling.

Objective: The objective was to determine the functional characteristics of a novel STAT5b mutation and describe the phenotype.

Patient: We describe an adult male patient with short stature [–5.9 SD score (SDS)], delayed puberty, and no history of pulmonary or immunological problems. GH-binding protein level as well as GH secretion characteristics were normal. Plasma prolactin level was elevated. Extremely low levels of IGF-I (–6.9 SDS), IGF-binding protein-3 (–12 SDS), and acid-labile subunit (–7.5 SDS) were found.

Results: We found a homozygous frameshift mutation in the STAT5b gene (nucleotide 1102–3insC, Q368fsX376), resulting in an inactive truncated protein, lacking most of the DNA binding domain and the SH2-domain.

Conclusions: This report confirms the essential role of STAT5b in GH signaling in the human. We show for the first time that immunological or pulmonary problems or elevated GH secretion are not obligatory signs of STAT5b deficiency, whereas hyperprolactinemia appears to be part of the syndrome. Therefore, in patients with severe short stature, signs of GH insensitivity, and a normal GHR, analysis of the STAT5b gene is recommended.




This article has been cited by other articles:


Home page
Genes Dev.Home page
L. Hennighausen and G. W. Robinson
Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B
Genes & Dev., March 15, 2008; 22(6): 711 - 721.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
M J E Walenkamp and J M Wit
Genetic disorders in the GH IGF-I axis in mouse and man
Eur. J. Endocrinol., August 1, 2007; 157(suppl_1): S15 - S26.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. G. Holloway, Y. Cui, E. V. Laz, A. Hosui, L. Hennighausen, and D. J. Waxman
Loss of Sexually Dimorphic Liver Gene Expression upon Hepatocyte-Specific Deletion of Stat5a-Stat5b Locus
Endocrinology, May 1, 2007; 148(5): 1977 - 1986.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
M. J E Walenkamp, S. Vidarsdottir, A. M Pereira, M. Karperien, J. van Doorn, H. A van Duyvenvoorde, M. H Breuning, F. Roelfsema, M F. Kruithof, J. van Dissel, et al.
Growth hormone secretion and immunological function of a male patient with a homozygous STAT5b mutation
Eur. J. Endocrinol., February 1, 2007; 156(2): 155 - 165.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society